Scientific Advisory Board

Geoffrey Block
Dr. Geoffrey Block is the Director of Research at Denver Nephrology Research, a department he founded in 1998 to provide translational research for patients with chronic kidney disease. His work focuses on mineral metabolism, cardiovascular disease (including anemia management) and reno-protective therapy (anti-inflammatory).  He has been the principal investigator on 95+ clinical trials spanning all phases of clinical research; has served on several international guideline committee workgroups, a steering committee member of several international clinical outcome clinical trials, and was recently elected to the executive committee of KDIGO (Kidney Disease: Improving Global Outcome).
Nuno Faria
Dr Nuno Faria works at the Bio-Mineral Research at the MRC’s Human Nutrition Research (‘‘HNR’’) Elsie Widdowson Laboratory in Cambridge. Within HNR, his work focuses on (i) the absorption of iron and diagnosis and treatment of iron deficiency; (ii) the role of minerals, in inflammatory and anti-inflammatory processes of the gastrointestinal tract and (iii) the development of novel mineral-based therapeutics. Dr Faria contributed to invention of the patented technology behind IHAT since Nemysis Ltd acquired the licence from the MRC in late 2017.
Carmen Gianfrani
Dr Carmen Gianfrani is an immunologist, Head of Mucosal Immunology Laboratory at the Institute of Protein Biochemistry – Italian National Council of Research (IBP CNR). Dr Gianfrani’ scientific interest is mainly focused on the pathogenesis of gluten related disorders and immunotherapies to recover oral tolerance to gluten proteins in celiac disease patients. She has also contributed to develop biochemical strategies detoxifying wheat gluten, that are currently in clinical trials. Dr Gianfrani is section editor of Pediatric Research and coordinator of Science Outreach Program at IBP CNR.
Dora Pereira
Dr Dora Pereira is a Research Group Leader at the Department of Pathology, University of Cambridge. Her research focuses on understanding the risk-benefit balance of oral iron in iron deficiency, the gut microbiome and enteric infections. She is a Principal Investigator with the MRC Unit The Gambia on a clinical trial investigating the safety and efficacy of oral iron supplements in young children. Dr Pereira contributed to invention of the patented technology behind IHAT.
Jonathan Powell
Professor Powell is Head of Bio-Mineral Research at the MRC’s Human Nutrition Research (‘‘HNR’’) Elsie Widdowson Laboratory in Cambridge. Within HNR, his work focuses on (i) the absorption of iron and diagnosis and treatment of iron deficiency; (ii) the role of minerals, in inflammatory and anti-inflammatory processes of the gastrointestinal tract and (iii) the development of novel mineral-based therapeutics. Dr Powell and his team were the inventors of the patented technology behind IHAT since Nemysis Ltd acquired the licence from the MRC in late 2017.